4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2020 / Meta-analysis of prospective cohort studies
A meta-analysis evaluated 20 prospective cohort studies assessing potato consumption and mortality risk. No significant associations were observed for all-cause mortality (0.90, 95% CI: 0.80 to 1.02, p = 0.096; 25,208 cases) or cancer mortality (1.09, 95% CI: 0.96 to 1.24, P = 0.204; 4,877 cases). Among three studies examining cardiovascular mortality (2,366 cases), two found no significant relationship.
Shows an association, not proof of cause and effect.
Darooghegi Mofrad M, Milajerdi A, Sheikhi A, et al. Crit Rev Food Sci Nutr, 2020. PMID 30638040
2020 / Cohort study and meta-analysis of prospective cohort studies
In an NHANES cohort of 24,856 participants (mean follow-up 6.4 years, 3,433 deaths), higher potato consumption was initially associated with higher risks of total (42%), CVD (65%), cerebrovascular (26%), and cancer (52%) mortality (p < 0.001), but these associations disappeared after adjustment for confounding factors. In a pooled meta-analysis of prospective studies (98,569 participants), potato intake showed no significant association with total (RR = 1.25, 95% CI 0.98-1.60), CVD (RR = 0.99, 95% CI 0.90-1.08), or stroke mortality (RR = 0.94, 95% CI 0.85-1.03). However, individuals with higher potato intake displayed less favorable cardiometabolic profiles, including higher waist circumference (97.2 vs. 99.5 cm) and worse blood pressure, triglycerides, HDL-C, and TG/HDL-C ratio (all p < 0.001).
Shows an association, not proof of cause and effect.
Mazidi M, Katsiki N, Mikhailidis DP, et al. Arch Med Sci, 2020. PMID 32190135
2020 / Meta-analysis of prospective cohorts
A meta-analysis of 12 cohort studies examined dietary protein intake and mortality. Higher plant protein intake was associated with lower all-cause mortality (RR 0.92, 95% CI: 0.88 to 0.96 for highest versus lowest; RR 0.97, 95% CI: 0.94 to 0.99 per 3% increment) and may be associated with reduced cardiovascular mortality (RR 0.90, 95% CI: 0.80 to 1.01). Higher animal protein intake was possibly linked to greater cardiovascular death risk (RR 1.11, 95% CI: 1.01 to 1.22). Total protein showed no clear association with mortality.
Shows an association, not proof of cause and effect.
Qi XX, Shen P Nutr Metab Cardiovasc Dis, 2020. PMID 32451273
2019 / Systematic review and meta-analysis of observational studies
Researchers analyzed 28 reports examining potato intake and chronic disease risks. Total potato consumption showed no associations with all-cause mortality (RR 0.88, 95% CI 0.69-1.12), coronary heart disease, stroke, or colorectal cancer per 150 g/day increase. Conversely, each 150 g/day increase in French fries intake was linked to higher risks of type 2 diabetes (RR 1.66, 95% CI 1.43-1.94) and hypertension (RR 1.37, 95% CI 1.15-1.63), based on mostly low- to moderate-certainty evidence.
Shows an association, not proof of cause and effect.
Schwingshackl L, Schwedhelm C, Hoffmann G, et al. Eur J Nutr, 2019. PMID 29987352
2019 / Systematic reviews and meta-analyses of prospective cohorts and trials
Researchers analyzed 185 prospective studies and 58 clinical trials examining carbohydrate quality markers. Observational data suggested a 15-30% decrease in all-cause and cardiovascular mortality, coronary heart disease, stroke, type 2 diabetes, and colorectal cancer when comparing highest versus lowest dietary fiber consumers. Clinical trials showed significantly lower bodyweight, systolic blood pressure, and total cholesterol with higher dietary fiber intakes. Similar findings were observed for whole grains, whereas evidence for low glycemic index or load showed smaller or no risk reductions.
Reynolds A, Mann J, Cummings J, et al. Lancet, 2019. PMID 30638909
2019 / Umbrella review of observational studies
An umbrella review examined quantitative syntheses of observational studies linking produce intake with health outcomes. Probable evidence was observed for cardiovascular protection, while possible evidence indicated lower risks of colon malignancies, depressive disorders, and pancreatic ailments for fruits. For vegetable consumption, possible evidence supported lower risks of stroke, hip fractures, colorectal malignancies, depression, and pancreatic conditions, though geographical location and sex were potential confounding factors.
Shows an association, not proof of cause and effect.
Angelino D, Godos J, Ghelfi F, et al. Int J Food Sci Nutr, 2019. PMID 30764679
2019 / Prospective cohort study and meta-analysis of prospective cohort studies
Researchers examined the link between low-carbohydrate diet (LCD) scores and mortality using NHANES (1999-2010) data and a pooled analysis of nine prospective cohort studies. In NHANES (24,825 participants), those in the lowest carbohydrate quartile had the highest risk of overall (32%), CVD (50%), cerebrovascular (51%), and cancer (36%) mortality compared to the highest carbohydrate intake quartile. In the pooled analysis of nine cohorts (462,934 participants), LCD was associated with higher overall (RR 1.22, 95% CI 1.06-1.39), CVD (RR 1.13, 95% CI 1.02-1.24), and cancer mortality (RR 1.08, 95% CI 1.01-1.14). The authors noted that causality cannot be proven and residual bias cannot be ruled out.
Shows an association, not proof of cause and effect.
Mazidi M, Katsiki N, Mikhailidis DP, et al. Eur Heart J, 2019. PMID 31004146
2019 / Systematic review of clinical studies
A systematic review evaluated 135 clinical studies from China comprising 9,474 cancer treatment cases involving the shiitake polysaccharide lentinan. Most cases involved lung (3,469), gastric (3,039), or colorectal (1,646) malignancies. Across evaluated reports, lentinan use was linked to better quality of life and greater efficacy of concurrent chemotherapy or radiation treatment.
Zhang M, Zhang Y, Zhang L, et al. Prog Mol Biol Transl Sci, 2019. PMID 31030752
2019 / Systematic review and meta-analysis
A meta-analysis of 23 studies evaluated iron exposure and breast malignancy risk. Comparing extreme categories, heme iron consumption was linked to higher risk (pooled RR 1.12, 95% CI: 1.04-1.22), as were elevated circulating iron levels (RR 1.22, 95% CI: 1.01-1.47). In contrast, food-derived, supplement-based, or combined total intakes exhibited no significant relationships with breast cancer risk.
Chang VC, Cotterchio M, Khoo E BMC Cancer, 2019. PMID 31170936
2019 / Umbrella review of meta-analyses of observational studies
An umbrella review examined 96 meta-analyses covering 40 unique health outcomes to assess associations with tea consumption. An increment of two to three cups per day was associated with reduced risks of total mortality, cardiac death, coronary artery disease, stroke, and type 2 diabetes mellitus, alongside beneficial associations for several cancers, skeletal, cognitive, and maternal outcomes. Harmful associations were identified for esophageal and gastric cancer when tea was consumed at temperatures above 55-60 °C. The authors state that randomized controlled trials are needed to determine causality.
Shows an association, not proof of cause and effect.
Yi M, Wu X, Zhuang W, et al. Mol Nutr Food Res, 2019. PMID 31216091
2019 / Meta-analysis of prospective cohorts
A meta-analysis evaluated 23 prospective cohorts involving 330,826 participants. Intake of soy products was inversely associated with cancer mortality (RR 0.88, 95% CI 0.79 to 0.99) and cardiovascular mortality (ES 0.85, 95% CI 0.72 to 0.99). Additionally, each 10-mg daily increment of soy isoflavones was linked to lower risk of death from all cancers and breast cancer, while soy protein was not tied to all-cause mortality.
Shows an association, not proof of cause and effect.
Nachvak SM, Moradi S, Anjom-Shoae J, et al. J Acad Nutr Diet, 2019. PMID 31278047
2019 / Systematic review and meta-analysis of cohort studies
A systematic review and meta-analysis of 118 articles (56 cohorts) with more than 6 million participants assessed meat intake and cancer outcomes. Low-certainty evidence suggested reducing unprocessed meat by 3 servings per week was associated with a very small lifetime reduction in overall cancer mortality. Evidence of low to very low certainty suggested reducing processed meat by 3 servings per week was associated with very small decreases in overall cancer mortality, prostate cancer mortality, and incidence of esophageal, colorectal, and breast cancer. Limitations included residual confounding, risk of bias from diet assessment and confounder adjustment, recall bias, and insufficient subgroup data.
Shows an association, not proof of cause and effect.
Han MA, Zeraatkar D, Guyatt GH, et al. Ann Intern Med, 2019. PMID 31569214
2019 / Systematic review and meta-analysis of prospective cohorts
Reviewers synthesized prospective cohort studies following participants for 2 to 34 years to evaluate dietary patterns with varying red and processed meat content. Low- to very-low-certainty evidence indicated that patterns lower in red and processed meat were linked to very small decreases in all-cause mortality, cardiovascular mortality, cancer mortality, and type 2 diabetes. Total sample sizes ranged from 4,000 to over 400,000 individuals across outcomes.
Shows an association, not proof of cause and effect.
Vernooij RWM, Zeraatkar D, Han MA, et al. Ann Intern Med, 2019. PMID 31569217
2018 / Dose-response meta-analysis of cohort studies
A meta-analysis of six studies including 5,984 breast cancer patients explored the dose-response relationship between circulating 25-hydroxyvitamin D levels and overall survival. Comparing the highest with the lowest vitamin D category yielded a pooled hazard ratio of 0.67 (95% CI: 0.56-0.79, P < .001). A linear dose-response analysis found a pooled hazard ratio for overall survival of 0.994 per 1 nmol/L (P for linear trend < .001), with increments of 10, 20, or 25 nmol/L at or above 23.3 nmol/L associated with 6%, 12%, and 14% lower risks of overall mortality. Authors note that better designed prospective cohort studies and clinical trials are needed to confirm these findings.
Shows an association, not proof of cause and effect.
Hu K, Callen DF, Li J, et al. Integr Cancer Ther, 2018. PMID 28589744
2018 / Systematic review and dose-response meta-analysis
A meta-analysis of 19 cohort studies including 1,041,692 participants and 96,710 deaths evaluated whole grain intake and mortality risk. Comparing highest versus lowest intake categories showed pooled relative risks of 0.84 (95% CI 0.81-0.88) for all-cause, 0.83 (95% CI 0.79-0.86) for cardiovascular, and 0.94 (95% CI 0.87-1.01) for cancer mortality. Each 28 g/day intake was associated with relative risks of 0.91, 0.86, and 0.97 for total, cardiovascular, and cancer mortality, respectively.
Zhang B, Zhao Q, Guo W, et al. Eur J Clin Nutr, 2018. PMID 29091078
2018 / Systematic review
Researchers identified six case series and reports comprising 39 participants with glioma, with no randomized clinical trials found. All included reports documented overall survival or progression-free survival, but each carried a high risk of bias. Because of the low-quality evidence, the clinical effectiveness of ketogenic dietary therapies for gliomas could not be determined.
Martin-McGill KJ, Srikandarajah N, Marson AG, et al. CNS Oncol, 2018. PMID 29658772
2018 / Systematic review and meta-analysis
A systematic review and meta-analysis of 14 articles including 8,097 lung cancer patients examined serum one-carbon metabolism factors. Compared with controls, lung cancer patients had lower serum folate (SMD -0.53, 95% CI -0.70 to -0.35, p = 0.001) and vitamin B6 (SMD -0.28, 95% CI -0.53 to -0.02, p = 0.001), but higher homocysteine levels (SMD 0.41, 95% CI 0.24 to 0.59, p = 0.001). No significant differences were seen for vitamin B12 (SMD -0.09, 95% CI -0.27 to 0.09, p = 0.202) or methionine (SMD -0.13, 95% CI -0.36 to 0.10, p = 0.001).
Shows an association, not proof of cause and effect.
Yang J, Li H, Deng H, et al. Front Oncol, 2018. PMID 30430082
2017 / Meta-analysis of prospective cohorts
A meta-analysis evaluated 15 prospective cohort studies examining dietary fat intake and mortality among women with breast cancer. Total fat intake was not associated with breast-cancer-specific death (HR 1.14, 95% CI 0.86-1.52) or all-cause mortality (HR 1.73, 95% CI 0.82-3.66). However, the highest versus lowest intake of saturated fat was linked to higher breast-cancer-specific death (HR 1.51, 95% CI 1.09-2.09, p < 0.01).
Shows an association, not proof of cause and effect.
Brennan SF, Woodside JV, Lunny PM, et al. Crit Rev Food Sci Nutr, 2017. PMID 25692500
2017 / Systematic review and meta-analysis of observational studies
A meta-analysis of 86 cross-sectional and 10 prospective cohort studies evaluated vegetarian and vegan diets against omnivorous diets. Prospective cohorts linked vegetarian diets to lower risk of ischemic heart disease incidence or mortality (RR 0.75, 95% CI 0.68 to 0.82) and total cancer incidence (RR 0.92, 95% CI 0.87 to 0.98), but found no link to all-cause or cardiovascular mortality. Vegan diets were associated with lower total cancer incidence (RR 0.85, 95% CI 0.75 to 0.95).
Shows an association, not proof of cause and effect.
Dinu M, Abbate R, Gensini GF, et al. Crit Rev Food Sci Nutr, 2017. PMID 26853923
2017 / Systematic review and meta-analysis of cohort studies
A systematic review identified 19 cohort studies on rice intake, chronic conditions, and mortality. In a meta-analysis of 12 cohorts, comparing extreme categories of rice intake showed a non-significant trend for total chronic diseases (RR 1.11, 95% CI: 0.96 to 1.29), with an association present in women (RR 1.40, 95% CI: 1.13 to 1.73) but not men (RR 0.95, 95% CI: 0.72 to 1.24). Across five cohorts, high intake was not associated with mortality overall (RR 0.97, 95% CI: 0.88 to 1.06), but linked to lower mortality in men (RR 0.87, 95% CI: 0.81 to 0.94).
Shows an association, not proof of cause and effect.
Saneei P, Larijani B, Esmaillzadeh A Public Health Nutr, 2017. PMID 27577106
2017 / Systematic review and dose-response meta-analysis of prospective studies
A systematic review and dose-response meta-analysis evaluated 95 prospective studies examining fruit and vegetable intake in relation to cardiovascular disease, cancer, and mortality. Per 200 g/day of combined fruit and vegetables, summary relative risks were 0.92 (95% CI: 0.90-0.94) for coronary heart disease, 0.84 (95% CI: 0.76-0.92) for stroke, 0.92 (95% CI: 0.90-0.95) for cardiovascular disease, 0.97 (95% CI: 0.95-0.99) for total cancer, and 0.90 (95% CI: 0.87-0.93) for all-cause mortality. Reductions in risk were observed up to 800 g/day for all outcomes except cancer (up to 600 g/day). Specific inverse associations with cardiovascular disease and mortality were reported for apples/pears, citrus fruits, green leafy vegetables, cruciferous vegetables, and salads.
Shows an association, not proof of cause and effect.
Aune D, Giovannucci E, Boffetta P, et al. Int J Epidemiol, 2017. PMID 28338764
2017 / Systematic review
A systematic review evaluated clinical evidence on isocaloric ketogenic diets in cancer patients. Evidence supporting benefits on tumor development, progression, or cancer therapy side effects was missing. In addition, multiple potential adverse effects were noted, leading authors to state that robust clinical evidence is required before recommending this diet for cancer.
Erickson N, Boscheri A, Linke B, et al. Med Oncol, 2017. PMID 28353094
2017 / Systematic review and meta-analysis
A systematic review evaluated 172 studies to assess whether milk intake influences prostate cancer via the insulin-like growth factor pathway. Moderate evidence indicated circulating IGF-I and IGFBP-3 increased with milk consumption. In meta-analyses, higher IGF-I was linked to increased prostate cancer risk (OR 1.09, 95% CI 1.03-1.16; 51 studies), while IGFBP-3 was linked to lower risk (OR 0.90, 95% CI 0.83-0.98; 39 studies).
Harrison S, Lennon R, Holly J, et al. Cancer Causes Control, 2017. PMID 28361446
2017 / Systematic review and meta-analysis of randomized controlled trials
A meta-analysis of five randomized trials examined calcium supplementation in 2,234 patients with prior colorectal adenomas. Good-quality trials showed calcium reduced recurrent adenomas (RR 0.88, 95% CI 0.79-0.99), with stronger effects at doses of at least 1,600 mg per day (RR 0.74, 95% CI 0.56-0.97), but advanced adenomas were not significantly affected (RR 1.02, 95% CI 0.67-1.55). Hypercalcemia incidence increased (P = .0095), and GRADE certainty was rated low.
Veettil SK, Ching SM, Lim KG, et al. Medicine (Baltimore), 2017. PMID 28796047